170 related articles for article (PubMed ID: 37756526)
21. FOXP3 promoter demethylation reveals the committed Treg population in humans.
Janson PC; Winerdal ME; Marits P; Thörn M; Ohlsson R; Winqvist O
PLoS One; 2008 Feb; 3(2):e1612. PubMed ID: 18286169
[TBL] [Abstract][Full Text] [Related]
22. Loss of TET proteins in regulatory T cells promotes abnormal proliferation, Foxp3 destabilization and IL-17 expression.
Nakatsukasa H; Oda M; Yin J; Chikuma S; Ito M; Koga-Iizuka M; Someya K; Kitagawa Y; Ohkura N; Sakaguchi S; Koya I; Sanosaka T; Kohyama J; Tsukada YI; Yamanaka S; Takamura-Enya T; Lu Q; Yoshimura A
Int Immunol; 2019 Apr; 31(5):335-347. PubMed ID: 30726915
[TBL] [Abstract][Full Text] [Related]
23. IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo.
Chen Q; Kim YC; Laurence A; Punkosdy GA; Shevach EM
J Immunol; 2011 Jun; 186(11):6329-37. PubMed ID: 21525380
[TBL] [Abstract][Full Text] [Related]
24. Dynamic Imprinting of the Treg Cell-Specific Epigenetic Signature in Developing Thymic Regulatory T Cells.
Herppich S; Toker A; Pietzsch B; Kitagawa Y; Ohkura N; Miyao T; Floess S; Hori S; Sakaguchi S; Huehn J
Front Immunol; 2019; 10():2382. PubMed ID: 31681278
[TBL] [Abstract][Full Text] [Related]
25. Induction of CD4
Khosravi M; Bidmeshkipour A; Moravej A; Hojjat-Assari S; Naserian S; Karimi MH
Immunol Res; 2018 Feb; 66(1):207-218. PubMed ID: 29143918
[TBL] [Abstract][Full Text] [Related]
26. Foxp3 TSDR Hypermethylation Is Correlated with Decreased Tregs in Patients with Unexplained Recurrent Spontaneous Abortion.
Zhu L; Liu M; Zhang S; Ou Y; Chen Y; Wei J; Su F; Chen H; Zhang J
Reprod Sci; 2021 Feb; 28(2):470-478. PubMed ID: 32839941
[TBL] [Abstract][Full Text] [Related]
27. CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression.
Arroyo Hornero R; Betts GJ; Sawitzki B; Vogt K; Harden PN; Wood KJ
Transplantation; 2017 Feb; 101(2):302-309. PubMed ID: 28118317
[TBL] [Abstract][Full Text] [Related]
28. VEGFR2 survival and mitotic signaling depends on joint activation of associated C3ar1/C5ar1 and IL-6R-gp130.
Hwang MS; Strainic MG; Pohlmann E; Kim H; Pluskota E; Ramirez-Bergeron DL; Plow EF; Medof ME
J Cell Sci; 2019 Mar; 132(6):. PubMed ID: 30765465
[TBL] [Abstract][Full Text] [Related]
29. [Effect of semaphorin-3A on the cellular stability of CD4
Gao Y; Li L; Liu Y; Li W; Wang Z; Shou S; Chai Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1454-1460. PubMed ID: 33541497
[TBL] [Abstract][Full Text] [Related]
30. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes.
McClymont SA; Putnam AL; Lee MR; Esensten JH; Liu W; Hulme MA; Hoffmüller U; Baron U; Olek S; Bluestone JA; Brusko TM
J Immunol; 2011 Apr; 186(7):3918-26. PubMed ID: 21368230
[TBL] [Abstract][Full Text] [Related]
31. Methylation-Sensitive Restriction Enzyme Quantitative Polymerase Chain Reaction Enables Rapid, Accurate, and Precise Detection of Methylation Status of the Regulatory T Cell (Treg)-Specific Demethylation Region in Primary Human Tregs.
Perry N; Wasko K; Cheng J; Tabbaa D; Marco E; Giannoukos G; Albright CF; Borges CM
J Immunol; 2021 Jan; 206(2):446-451. PubMed ID: 33277386
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Helios gene expression and Foxp3 TSDR methylation in the newly diagnosed Rheumatoid Arthritis patients.
Zafari P; Yari K; Mostafaei S; Iranshahi N; Assar S; Fekri A; Taghadosi M
Immunol Invest; 2018 Aug; 47(6):632-642. PubMed ID: 29851536
[TBL] [Abstract][Full Text] [Related]
33. Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells.
Arroyo-Olarte RD; Flores-Castelán JC; Armas-López L; Escobedo G; Terrazas LI; Ávila-Moreno F; Leon-Cabrera S
Inflammation; 2024 May; ():. PubMed ID: 38700792
[TBL] [Abstract][Full Text] [Related]
34. Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity.
Ferreira RC; Simons HZ; Thompson WS; Rainbow DB; Yang X; Cutler AJ; Oliveira J; Castro Dopico X; Smyth DJ; Savinykh N; Mashar M; Vyse TJ; Dunger DB; Baxendale H; Chandra A; Wallace C; Todd JA; Wicker LS; Pekalski ML
J Autoimmun; 2017 Nov; 84():75-86. PubMed ID: 28747257
[TBL] [Abstract][Full Text] [Related]
35. Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation.
Someya K; Nakatsukasa H; Ito M; Kondo T; Tateda KI; Akanuma T; Koya I; Sanosaka T; Kohyama J; Tsukada YI; Takamura-Enya T; Yoshimura A
Int Immunol; 2017 Aug; 29(8):365-375. PubMed ID: 29048538
[TBL] [Abstract][Full Text] [Related]
36. Induction and maintenance of regulatory T cells by transcription factors and epigenetic modifications.
Iizuka-Koga M; Nakatsukasa H; Ito M; Akanuma T; Lu Q; Yoshimura A
J Autoimmun; 2017 Sep; 83():113-121. PubMed ID: 28709726
[TBL] [Abstract][Full Text] [Related]
37. Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region.
Rossetti M; Spreafico R; Saidin S; Chua C; Moshref M; Leong JY; Tan YK; Thumboo J; van Loosdregt J; Albani S
J Immunol; 2015 Jan; 194(1):113-24. PubMed ID: 25452562
[TBL] [Abstract][Full Text] [Related]
38. All-Trans Retinoic Acid Induces CD4+CD25+FOXP3+ Regulatory T Cells by Increasing FOXP3 Demethylation in Systemic Sclerosis CD4+ T Cells.
Sun X; Xiao Y; Zeng Z; Shi Y; Tang B; Long H; Kanekura T; Wang J; Wu H; Zhao M; Lu Q; Xiao R
J Immunol Res; 2018; 2018():8658156. PubMed ID: 29854846
[TBL] [Abstract][Full Text] [Related]
39. Helios expression and Foxp3 TSDR methylation of IFNy+ and IFNy- Treg from kidney transplant recipients with good long-term graft function.
Trojan K; Unterrainer C; Weimer R; Bulut N; Morath C; Aly M; Zhu L; Opelz G; Daniel V
PLoS One; 2017; 12(3):e0173773. PubMed ID: 28296931
[TBL] [Abstract][Full Text] [Related]
40. Assessment of regulatory T cells (Tregs) and Foxp3 methylation level in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy.
Sabir SF; Matti BF; Alwatar WMA
Immunogenetics; 2023 Apr; 75(2):145-153. PubMed ID: 36567345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
